TrialReader


Effect of Ulinastatin on Postoperative Renal Function in Patients Undergoing Robot-assisted Laparoscopic Partial Nephrectomy

NCT02258906 — Not applicable, Completed, 66 participants, Yonsei University

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  
RegistryNCT02258906
StatusCompleted
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: double, prevention
Enrollment66 (Actual)
SponsorYonsei University (Other)
ConditionsRenal Mass
Interventionsulinastatin, normal saline (Drug)
Datesstart 2014-10-01, primary completion 2016-07-01, completion 2016-07-01, first posted 2014-10-08, last updated 2016-08-25
Locations1 site in South Korea

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Renal Mass All trials of ulinastatin All trials of normal saline

-Summary

Ulinastatin reduces systemic inflammatory responses and protects organs from ischemia/reperfusion-induced injury. The aim of this study is to evaluate the effect of ulinastatin on postoperative renal function in patients undergoing robot-assisted laparoscopic partial nephrectomy. Seventy patients, aged 20 to 79 years, scheduled for robot-assisted laparoscopic partial nephrectomy will be divided into ulinastatin (n=35) and control (n=35) groups. Randomly selected patients of the ulinastatin group are given ulinastatin. In contrast, patients in the control group receive an equivalent volume of normal saline as a placebo. The primary endpoints are postoperative renal function measured by serum creatinine, cystatin C, and urine output.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
Ulinastatin groupExperimentalDrug: ulinastatinPatients in the ulinastatin group are given ulinastatin during operation.
control groupPlacebo comparatorDrug: normal salinePatients in the control group receive the same volume of normal saline during operation.
  • ulinastatin (Drug)
  • normal saline (Drug)

+Outcome measures

Primary outcomes

  • postoperative renal function [for 3 days after surgery]: Postoperative renal function measured by serum creatinine, cystatin C, and urine output

Secondary outcomes

  • systemic inflammatory response [for 3 days after surgery]: the systemic inflammatory response measured by WBC, Neutrophil (%), and CRP

+Eligibility

Sex: All, ages: 20 Years to 79 Years

Inclusion Criteria:

* patients who are scheduled to undergo robot-assisted laparoscopic partial nephrectomy with an American Society of Anesthesiologists (ASA) physical status I-III

Exclusion Criteria:

* Subjects are ineligible if they have severe respiratory or cardiovascular disease, renal insufficiency before operation, cognitive dysfunction, are unable to communicate or speak Korean

+Locations (1)

FacilityCityCountryStatus
Severance Hospital, Yonsei University College of MedicineSeoulSouth Korea

My Notes